CuraCell

CuraCell is a cell therapy company focused on transforming cancer treatment through Tumor Infiltrating Lymphocyte (TIL)-based therapies. We aim to use the patient’s own immune system to create personalized and effective treatments for solid tumors, which account for the majority of cancer diagnoses. Our innovative process improves how TILs are prepared, allowing us to produce more cells in less time. This approach, combined with tailored treatment plans, is designed to help patients achieve long-lasting results. CuraCell works closely with leading cancer centers to bring these therapies to patients. We are currently conducting clinical trials to explore new ways to improve outcomes for those with solid tumors. At CuraCell, we are driven by a commitment to innovation and collaboration. Whether you are a partner, investor, or professional looking to make a difference in cancer care, we welcome you to connect with us.